Lymphography and computed tomography in lymph node metastases from malignant melanoma

Area of Science:

• Oncology
• Radiology
• Surgical Pathology

Background:

• Malignant melanoma can metastasize to lymph nodes, requiring accurate staging for treatment.
• Clinical examination of lymph nodes is often unreliable for detecting melanoma metastasis.
• Pre-operative imaging modalities are crucial for assessing lymph node involvement.

Purpose of the Study:

• To compare the diagnostic accuracy of contrast lymphography and computed tomography (CT) for detecting lymph node metastases in patients with suspected malignant melanoma.
• To evaluate the effectiveness of combined imaging techniques in identifying melanoma spread to lymph nodes.
• To assess the inadequacy of current clinical and radiologic methods for melanoma lymph node staging.

Main Methods:

• Prospective study involving 49 patients with suspected lymph node metastases from malignant melanoma.
• Performance of contrast lymphography and regional computed tomography (CT) prior to lymph node dissection.
• Analysis of sensitivity, specificity, and concordance rates for each modality and their combination.
• Comparison with clinical lymph node examination findings.

Main Results:

• Computed tomography (CT) demonstrated higher specificity (83%) and sensitivity (70%) compared to lymphography (62% sensitivity, 70% specificity).
• Combined imaging sensitivity was 79% and specificity was 84%, outperforming individual methods.
• Clinical lymph node examination showed poor accuracy (42% true positive, 58% false positive).
• Lymphography yielded excessive false positives and negatives, limiting its standalone utility.

Conclusions:

• Computed tomography (CT) is superior to lymphography for detecting upper extremity lymph node metastases in melanoma.
• Combined imaging modalities offer improved diagnostic accuracy but are still insufficient for definitive staging.
• Current clinical and radiologic techniques are inadequate for reliably detecting lymph node metastases in malignant melanoma, necessitating further research.